Dr. James I. Bicher, was born in San Cristobal, Santa Fe in Argentina on May 12th, 1937. At age 16, James Bicher, MD entered the University of Buenos Aires Medical School but completed his studies in 1962 at the Hadassah Medical School in Jerusalem, Israel, where he and his family had immigrated.
In 1962 to 1968, after completing his internship at the Beilinson Hospital in Petah-Tiqya, Israel, Dr. James I. Bicher was a lecturer in Physiology and Pharmacology for Tel Aviv University; a research supervisor for Pharmacological Screening Program and the senior scientist for Rogoff Medical Research Institute at the Beilinson Hospital in Israel.
For the next 5 years until 1973, Dr. James I. Bicher was an Associate in Anatomy, an Assistant Professor of Anatomy and an Associate Professor of Anatomy and Research Medicine at the Medical University in Charleston, South Carolina.
In 1973 to 1976, James Bicher, MD was the Associate Professor in Pharmacology and completed his residency in Radiation Therapy in 1974 at the University of Arkansas for Medical Sciences in Little Rock, Arkansas. In 1976, Dr. James I. Bicher completed his second residency in Radiation Therapy and was the Associate Chief of the Department of Radiation Medicine at Roswell Park Memorial Institute in Buffalo, New York until 1978.
From 1978 to 1981, James Bicher, MD was the director for the Non-Ionizing Radiation Cancer Treatment Center at Henry Ford Hospital in Detroit, Michigan. In 1982 to 1985, James Haim I. Bicher was the Chief of the Hyperthermic Clinic for Western Tumor Medical Group in Van Nuys, California.
Since 1985 to today, James Bicher, MD is the founder and director of Valley Cancer Institute, located in Los Angeles, California and the Senior Consultant for Beritashvili Institute of Physiology, Georgian Academy of Sciences, Republic of Georgian, USSR since 1991 to today.
James Bicher, MD licensure includes the FLEX and ECFMG, the Arkansas Healing Arts Certificate and the Arkansas Medical License, the New York Medical License, the Michigan Medical License, the ABR Certification in Radiation Therapy and the California Medical License.
Dr. James I. Bicher honors begin from him being the President and Founder of the American Society of Clinical Hyperthermic Oncology (ASCHO), to being awarded the Zondec Award at Hadassah Medical School in Jerusalem in 1962. Being the Secretary from 1972 to 1981 and President in 1981 of the International Society of Oxygen Transport of Tissue to another honor for the Travel Award at the sixth International Congress of Radiation Research, 1979. James Bicher, MD is also the Founder and Past President of the North American Hyperthermia Group (NAHG) and a Member of the National Committee on Hyperthermia.
James Bicher, MD academic appointments vary from a clinical Associate Professor in Radiology at the State University of New York(SUNY) in 1977 and 1978 to an Associate Professor of the Department of Biology at Wayne State University in Detroit, Michigan from 1978 to 1982.
Dr. James I. Bicher specialization trip include 6 months at the Institute of Pharmacology in Bonn University (Prof. R. Domenjoz) between 1964 and 1965.
James Bicher, MD has a wide variety of professional reviewer or editorial appointment within several years. The Reviewer for NATIONAL SCIENCE FOUNDATION in 1976, the Editorial Board of MICROVASCULAR RESEARCH in 1976, the Editorial Board of NEUROLOGICAL SCIENCES in 1977, the Reviewer for RADIOLOGY and MICROVASCULAR RESEARCH for 1978, the Reviewer for RADIOLOGY and MICROVASCULAR RESEARCH for 1979, the Reviewer for RADIOLOGY and MICROVASCULAR RESEARCH for 1980 and James Bicher, MD was also the Associate Editor of ENDOCURIETHERAPIE/HYPERTHERMIC ONCOLOGY-an International Journal in 1985. James Bicher, MD professional consultant-ship includes: Bristol Laboratories, 1965aE’1971, Schering Corporation, 1965aE’1971, Transidyne General Corporation, 1969aE’1971, Kabi-Stockholm, 1971aE’1972 and MediScience Technology, Inc. 1971aE’1975.
Dr. James I. Bicher has several patents under his name:
3832994- Cardiac Monitor45
365431- Catheter System for Blood Gas Monitoring
392065- Cardiographic Signal Processing
370048- Blood Cell Aggregometer
433260- External Microwave Applicator and Method
160217- Microwave Antenna System for Intracavitary Insertion
4369795- Implantable Micro-thermocouple Member
There are many Professional Societies James Bicher, MD belongs to. The following are: the American Society of Therapeutic radiologists (ASTR), the American Microcirculatory Society, the European Society of Microcirculation, the International Society on Oxygen Transport of Tissue (Past President), the North American Hyperthermia Group (Founder and Past President) (Currently “Society For Thermal Medicine”), the European Society of Hyperthermic Oncology(ESHO) (Founding Member), the Radiation Research Society, the Western Hyperthermia Group (Founder), the American Society of Clinical Hyperthermic Oncology (Founder and President from 1985aE’1986), the International Clinical Hyperthermia Society (ICHS) Founder member and past president (1999) and the Current board member and American Vice-President. vci.org/cancer_treatments_miscell/valleycancerinstitute_founder.htm
Founder and director of Bicher Cancer Institute (formerly Valley Cancer Institute), Dr. Bicher has been committed to the research, development, and clinical use of Hyperthermia, the application of concentrated therapeutic heat to treat cancer. It is the process of applying energy to elevate the temperature of cancer cells – in order to destroy or damage the tumor. Although, Hyperthermia does come from Germany, clinics in Germany do whole body Hyperthermia, which is not approved in the U.S. At BCI, we do local Hyperthermia combined with low-dose radiation, implemented, and developed by Dr. James I. Bicher in the 70′s and 80′s. We go even further by adding the targeted radiation in the form of IMRT “Intensity-Modulated Radiation Therapy”, an advanced cancer treatment therapy not done anywhere else! Hyperthermia in conjunction with low-dose IMRT is purposely intended to cure when tumors are localized. This approach has a curative intent, as opposed to palliative treatment used in conventional therapies like radiation alone, high toxic chemotherapy, and the “point of no return”, surgery, whose purpose is only to prolong patients’ lives.
Bicher Cancer Institute encompasses two (2) 6,000 sq. ft. facilities in Los Angeles area, Culver City and newly expanded second facility located in Beverly Hills, California, includes the most advanced hyperthermic technology: two linear accelerators with pinpointed radiation therapy, IMRT, research laboratories, seven Hyperthermia treatment rooms, and full radiation and medical oncology departments, capable of treating up to 60 patients e Using a holistic approach, the combination of the natural heat treatment with the other established anti-cancer modalities, allows for good treatment results in most tumors, while markedly decreasing the level of toxicity. BCI’s medical expertise is based on 25 years of clinical experience and research in the development of alternative cancer treatments. Most of the Institute’s oncology staff, including doctors, nurses, hyperthermia and radiology technicians, and engineers, have been with BCI from the first years of its establishment and possesses decades of expertise in the field of cancer treatment with curative intent.
“I believe in using the forces
of nature to create a medicine which utilizes
these forces—applying scientific methods
and adapting them in a natural way—
to harm the body as little as possible.
HYPERTHERMIA
fully meets these criteria.”
~James I. Bicher
